143 related articles for article (PubMed ID: 2970871)
1. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
Pui CH; Ip SH; Dodge RK; Carrabis S; Brown M; Crist WM; Berard CW; Kung P; Dahl GV; Murphy SB
Blood; 1988 Sep; 72(3):1015-21. PubMed ID: 2970871
[TBL] [Abstract][Full Text] [Related]
2. Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome.
Pui CH; Ip SH; Thompson E; Dodge RK; Brown M; Wilimas J; Carrabis S; Kung P; Berard CW; Crist WM
Blood; 1989 Jan; 73(1):209-13. PubMed ID: 2521294
[TBL] [Abstract][Full Text] [Related]
3. High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma.
Pui CH; Ip SH; Kung P; Dodge RK; Berard CW; Crist WM; Murphy SB
Blood; 1987 Sep; 70(3):624-8. PubMed ID: 3113511
[TBL] [Abstract][Full Text] [Related]
4. Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemia.
Pui CH; Dodge RK; Dahl GV; Rivera G; Look AT; Kalwinsky D; Bowman WP; Ochs J; Abromowitch M; Mirro J
Blood; 1985 Oct; 66(4):778-82. PubMed ID: 3862434
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malifnancies.
Coccia PF; Kersey JH; Gajil-Peczalska KJ; Krivit W; Nesbit ME
Am J Hematol; 1976; 1(4):405-17. PubMed ID: 795293
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia.
Pui CH; Williams DL; Kalwinsky DK; Look AT; Melvin SL; Dodge RK; Rivera G; Murphy SB; Dahl GV
Blood; 1986 Jun; 67(6):1688-92. PubMed ID: 2939898
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia.
Pui CH; Ip SH; Iflah S; Behm FG; Grose BH; Dodge RK; Crist WM; Furman WL; Murphy SB; Rivera GK
Blood; 1988 Apr; 71(4):1135-7. PubMed ID: 3128348
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Gause A; Verpoort K; Roschansky V; Tschiersch A; Hasenclever D; Schmits R; Diehl V; Brosteanu O; Pfreundschuh M
Ann Oncol; 1991 Sep; 2(8):579-83. PubMed ID: 1724380
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
10. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
11. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis.
Smith GM; Biggs J; Norris B; Anderson-Stewart P; Ward R
J Clin Immunol; 1997 Nov; 17(6):502-9. PubMed ID: 9418191
[TBL] [Abstract][Full Text] [Related]
12. Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in children.
Pui CH; Williams DL; Raimondi SC; Melvin SL; Behm FG; Look AT; Dahl GV; Rivera GK; Kalwinsky DK; Mirro J
Leuk Res; 1986; 10(11):1287-92. PubMed ID: 2948078
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibodies of the ICO series against differentiation antigens of human lymphocytes].
Baryshnikov AIu
Gematol Transfuziol; 1990 Aug; 35(8):4-7. PubMed ID: 2253863
[TBL] [Abstract][Full Text] [Related]
14. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
15. A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells.
Morimoto C; Rudd CE; Letvin NL; Schlossman SF
Nature; 1987 Dec 3-9; 330(6147):479-82. PubMed ID: 2446140
[TBL] [Abstract][Full Text] [Related]
16. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
17. Analysis of surface antigen profile, TdT expression, and T cell receptor gene rearrangement for maturational staging of leukemic T cells: a pediatric oncology group study.
Morabito F; Prasthofer EF; Pullen DJ; Mahoney D; Downing JR; Crist WM; Grossi CE
Leukemia; 1987 Jun; 1(6):514-7. PubMed ID: 3499547
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies.
Roper M; Crist WM; Metzgar R; Ragab AH; Smith S; Starling K; Pullen J; Leventhal B; Bartolucci AA; Cooper MD
Blood; 1983 May; 61(5):830-7. PubMed ID: 6338974
[TBL] [Abstract][Full Text] [Related]
19. Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia.
Pui CH; Schell MJ; Vodian MA; Kline S; Mirro J; Crist WM; Behm FG
Leukemia; 1991 Mar; 5(3):249-54. PubMed ID: 1901614
[TBL] [Abstract][Full Text] [Related]
20. The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
Knowles DM
Hum Pathol; 1986 Jan; 17(1):14-33. PubMed ID: 3002948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
